Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TOP1 | P11387 | 3/20 | 0.43 |
| ▸ | CYCS | P99999 | 3/20 | 0.42 |
| ▸ | MMP2 | P08253 | 1/20 | 0.41 |
| ▸ | MMP9 | P14780 | 1/20 | 0.41 |
| ▸ | MMP8 | P22894 | 1/20 | 0.41 |
| ▸ | MMP13 | P45452 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | HPGD | P15428 | 3/20 | 0.41 |
| ▸ | GLA | P06280 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.39 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.38 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.38 |
| ▸ | GRIK3 | Q13003 | 1/20 | 0.38 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.38 |
| ▸ | STAT3 | P40763 | 1/20 | 0.37 |
| ▸ | STAT1 | P42224 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29358276 | 1.00 | TOP1 (0.43) | TOP1CYCSMMP2MMP9MMP8 | |
| SCHEMBL11341449 | 0.99 | TOP1 (0.42) | TOP1CYCSMMP2MMP9MMP8 | |
| SCHEMBL28492100 | 0.99 | TOP1 (0.42) | TOP1CYCSMMP2MMP9MMP8 | |
| SCHEMBL28351380 | 0.99 | TOP1 (0.42) | TOP1CYCSMMP2MMP9MMP8 | |
| SCHEMBL28355123 | 0.99 | TOP1 (0.42) | TOP1CYCSMMP2MMP9MMP8 | |
| Hydrochloric Acid SCHEMBL16188274 | 0.99 | KDM4E (0.43) | TOP1CYCSMMP2MMP9MMP8 | |
| SCHEMBL30632112 | 0.99 | TOP1 (0.42) | TOP1CYCSMMP2MMP9MMP8 | |
| SCHEMBL11293563 | 0.99 | TOP1 (0.42) | TOP1CYCSMMP2MMP9MMP8 | |
| SCHEMBL29062055 | 0.99 | TOP1 (0.42) | TOP1CYCSMMP2MMP9MMP8 | |
| SCHEMBL28452941 | 0.99 | TOP1 (0.42) | TOP1CYCSMMP2MMP9MMP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1715 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122057527-A | Hydrodewaxing polycyclic aromatic hydrocarbon catalyst, preparation method and application thereof | 中国石油化工股份有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-122037220-A | Porphyrin-Cu2+Complex nano-sheet and preparation method and application thereof | 河南省科学院激光制造研究所 | 2026-05-15 | — | — | CN | claimed |
| CN-122005794-A | MOF-based composite sensitizer and preparation method and application thereof | 理工清科(重庆)先进材料研究院有限公司 | 2026-05-12 | — | — | CN | claimed |
| CN-122005903-A | Temperature-sensitive hydrogel dressing and preparation method and application thereof | 十堰市太和医院（湖北医药学院附属医院） | 2026-05-12 | — | — | CN | claimed |
| CN-122016778-A | Method for detecting ferrous ions of heavy metals in environment | 南京师范大学 | 2026-05-12 | — | — | CN | claimed |
| US-12542215-B2 | Detection of early-stage lung cancer in sputum using automated flow cytometry and machine learning | BIOAFFINITY TECHNOLOGIES, INC. (US) | 2026-02-03 | — | — | US | claimed |
| WO-2025125384-A1 | HYDROGEL COMPOSITIONS | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2025-06-19 | — | — | WO | claimed |
| WO-2025125382-A1 | MOF NANOPARTICLES | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2025-06-19 | — | — | WO | claimed |
| CN-120131953-A | Targeted nano-drug with sonodynamic activity, and preparation method and application thereof | 中山大学·深圳 | 2025-06-13 | — | — | CN | claimed |
| CN-120137190-A | Carboxyl lithium porphyrin supermolecule fast-charging anode material of lithium ion battery, and preparation method and application thereof | 山东大学 | 2025-06-13 | — | — | CN | claimed |
| US-20060002822-A1 | Oxygen sensitive probe | AGILENT TECHNOLOGIES, INC. | 2006-01-05 | — | — | US | claimed |
| US-20050245673-A1 | Care and/or make-up cosmetic composition structured with silicone polymers and organogelling agents, in rigid form | L'OREAL S.A. (FR) | 2005-11-03 | — | — | US | claimed |
| EP-1515684-A2 | CARE AND/OR MAKE-UP COSMETIC COMPOSITION STRUCTURED WITH SILICONE POLYMERS AND ORGANOGELLING AGENTS, IN RIGID FORM | L'OREAL (FR) | 2005-03-23 | — | — | EP | claimed |
| US-20040116500-A1 | Methods and compositions to treat lung diseases | SAKALOSKY GEORGE P (US) | 2004-06-17 | — | — | US | claimed |
| WO-2003105788-A2 | CARE AND/OR MAKE-UP COSMETIC COMPOSITION STRUCTURED WITH SILICONE POLYMERS AND ORGANOGELLING AGENTS, IN RIGID FORM | L'OREAL (FR) | 2003-12-24 | — | — | WO | claimed |
| US-6660762-B2 | Administering porphyrin compound; respiratory system disorders | SAKALOSKY GEORGE P (US) | 2003-12-09 | — | — | US | claimed |
| US-20030004204-A1 | Methods and compositions to treat lung diseases | SAKALOSKY GEORGE P (US) | 2003-01-02 | — | — | US | claimed |
| EP-0811626-B1 | Use of metallo-porphyrin conjugates for the detection of biological substances | ROCHE DIAGNOSTICS GMBH (DE) | 2002-08-14 | — | — | EP | claimed |
| US-6004530-A | REACTING METALLO-PORPHYRIN HAVING ONE TO FOUR CARBOXYLIC ACID GROUPS WITH CARBODIIMIDE, 1-HYDROXYBENZOTRIAZOLE AND ACTIVE ESTER COUPLING AGENT TO FORM ACTIVE ESTER | ROCHE DIAGNOSTICS GMBH (DE) | 1999-12-21 | — | — | US | claimed |
| EP-0811626-A1 | Use of metallo-porphyrin conjugates for the detection of biological substances | Roche Diagnostics GmbH (DE) | 1997-12-10 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030004204-A1 | Methods and compositions to treat lung diseases | PPOX, BPGM, CLN6 | TOP1 596/4885CYCS 448/4885MMP2 3680/4885 |
| US-12542215-B2 | Detection of early-stage lung cancer in sputum using automated flow cytometry and machine learning | CD14, CTSL, MKI67 | TOP1 813/4885CYCS 352/4885MMP2 1121/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.